Key result
Higher endogenous insulin secretion linked to increased arterial stiffness in nondiabetic hypertension.
Why the study?
The study aimed to explore the relationship between plasma insulin secretion and arterial stiffness in nondiabetic essential hypertensive patients.
Does higher endogenous insulin secretion associate with increased arterial stiffness in nondiabetic essential hypertensive patients?
Cross-Sectional (n=730)
No
Does higher endogenous insulin secretion associate with increased arterial stiffness in nondiabetic essential hypertensive patients?
Elevated endogenous insulin secretion is independently associated with increased arterial stiffness in essential hypertension, highlighting a potential mechanism of vascular damage prior to the onset of diabetes.
Higher insulin secretion was associated with arterial stiffness in nondiabetic hypertension; leaves open causal contribution and need for prospective validation.
The study aims to explore the relationship between plasma insulin secretion and arterial stiffness in nondiabetic essential hypertensive patients. A total of 730 nondiabetic essential hypertensive patients registered between January 2016 and October 2020 were enrolled. A two-hour oral glucose tolerance test (OGTT) was performed to detect the levels of C-peptide and blood glucose at 0 hours and 2 hours, as well as the difference between C-peptide (Δ C-peptide) and blood glucose (Δ blood glucose) over the same period. Patients were divided into two groups: the normal glucose tolerance (NGT) group (n = 322) and the impaired glucose tolerance (IGT) group (n = 408). A multiple linear regression analysis was used to evaluate the association between brachial-ankle pulse wave velocity (baPWV) and the other factors. 0 h C-peptide, 2 h C-peptide, and Δ C-peptide were found to be higher in the IGT group. baPWV was positively linear correlated with 2 h C-peptide (r = 0.086, <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>p</a:mi> <a:mo>=</a:mo> <a:mn>0.020</a:mn> </a:math> ) and Δ C-peptide (r = 0.115, <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>p</c:mi> <c:mo>=</c:mo> <c:mn>0.002</c:mn> </c:math> ). baPWV remained independently associated with 0 h C-peptide, 2 h C-peptide, and Δ C-peptide, after adjusting by age, gender, smoking, body mass index (BMI), high-density lipoprotein (HDL), cholesterol, systolic blood pressure (SBP), and triglycerides (TG). Our data shows that higher endogenous insulin secretion might play an important role in the progression of arterial stiffness in nondiabetic essential hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) conducted a cross-sectional in Nondiabetic essential hypertension (n=730). Endogenous insulin secretion (assessed by C-peptide levels) was evaluated on Arterial stiffness assessed by brachial-ankle pulse wave velocity (baPWV) (β = 0.078 (for Δ C-peptide), p=0.014). Higher endogenous insulin secretion, assessed by Δ C-peptide (β=0.078, p=0.014) and 2h C-peptide (β=0.089, p=0.006), was independently associated with increased arterial stiffness in nondiabetic essential hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: